R
RAFAEL HOLDINGS, INC.
NYSE: RFL (Rafael Holdings, Inc.)
Last update: yesterday, 4:25AM2.07
-0.13 (-5.91%)
| Previous Close | 2.20 |
| Open | 2.11 |
| Volume | 296,266 |
| Avg. Volume (3M) | 191,864 |
| Market Cap | 72,660,520 |
| Price / Sales | 70.49 |
| Price / Book | 0.900 |
| 52 Weeks Range | |
| Earnings Date | 12 Jun 2025 - 16 Jun 2025 |
| Operating Margin (TTM) | -1,633.43% |
| Diluted EPS (TTM) | -0.920 |
| Quarterly Revenue Growth (YOY) | 7.70% |
| Total Debt/Equity (MRQ) | 0.82% |
| Current Ratio (MRQ) | 3.85 |
| Operating Cash Flow (TTM) | -11.44 M |
| Levered Free Cash Flow (TTM) | -6.60 M |
| Return on Assets (TTM) | -9.82% |
| Return on Equity (TTM) | -26.78% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Real Estate Services (US) | Bearish | Mixed |
| Real Estate Services (Global) | Bearish | Mixed | |
| Stock | Rafael Holdings, Inc. | - | - |
AIStockmoo Score
-1.1
| Analyst Consensus | -2.0 |
| Insider Activity | NA |
| Price Volatility | -4.5 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | 2.0 |
| Average | -1.13 |
|
Rafael Holdings Inc, through its subsidiaries, is a clinical stage, oncology-focused pharmaceutical company committed to the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. The company is a significant investor in two clinical stage oncology companies, Cornerstone Pharmaceuticals, Inc., and LipoMedix Pharmaceuticals Ltd. |
|
| Sector | Real Estate |
| Industry | Real Estate Services |
| Investment Style | Small Value |
| % Held by Insiders | 54.75% |
| % Held by Institutions | 9.38% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Epiq Capital Group, Llc | 31 Dec 2024 | 243,030 |
| Ieq Capital, Llc | 31 Mar 2025 | 238,878 |
| Founders Fund V Management, Llc | 31 Mar 2025 | 169,451 |
| Founders Fund Vi Management, Llc | 31 Mar 2025 | 38,784 |
No data within this time range.
| 5Y Average Dividend Yield | 0.00% |
| Ex Date | Announcement Date | Payment Date | Details |
|---|---|---|---|
| 19 May 2010 | 27 May 2010 | 28 May 2010 | 12.818541 Cash |
| 18 Dec 2009 | 17 Dec 2009 | 31 Dec 2009 | 0.020211 Cash |
| 19 Jun 2009 | 18 Jun 2009 | 30 Jun 2009 | 0.014519 Cash |
| 20 Mar 2009 | 19 Mar 2009 | 31 Mar 2009 | 0.024223 Cash |
| 19 Dec 2008 | 18 Dec 2008 | 31 Dec 2008 | 0.140558 Cash |
| 19 Sep 2008 | 18 Sep 2008 | 30 Sep 2008 | 0.163271 Cash |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |